Innovent Biologics
Farah Dahman, MPA, currently serves as Associate Director of Clinical Project Management at Innovent Biologics since April 2024 and also works as a Lagree Pilates instructor and coach at [solidcore] since December 2024. Previously, Farah held the position of Senior Clinical Project Manager at IQVIA from November 2021 to April 2024 and was employed at Memorial Sloan Kettering Cancer Center from September 2016 to November 2021, where roles included Senior Project Manager, Project Manager in Clinical Operations, Clinical Research Supervisor, and Project Coordinator. Prior experience includes serving as Grants and Contracts Administrator and Clinical Research Coordinator at Virginia Commonwealth University from August 2014 to July 2016. Farah earned a Master’s Degree in Health Policy and Management from NYU Robert F. Wagner Graduate School of Public Service (2016-2020) and a Bachelor of Science in Biochemistry from Virginia Commonwealth University (2010-2014).
This person is not in any teams
This person is not in any offices
Innovent Biologics
2 followers
Innovent Biologics, Inc. is a China-based biopharmaceutical company. The Company's main products include PD-1 antibody; bevacizumab (Avastin) biosimilar, IBI-305; rituximab (MabThera/Rituxan) biosimilar, IBI-301; and adalimumab (Humira) biosimilar, IBI-303.